OL-002 Effect of high-dose ribavirin (RBV), Alinia (Nitazoxanide) and pegylated interferon (PegIFN) alfa-2a in attaining sustained virologic response (SVR) in treatment of chronic hepatitis C (ERAIS-C Trial) in naive genotype 1 patients

✍ Scribed by P.P. Basu; K. Rayapudi; T. Pacana; N.J. Shah; N. Krishnaswamy; H. Hampole; C. Tang; R. Brown

• Book ID: 118617339
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 224 KB
• Volume: 14
• Category: Article
• ISSN: 1201-9712
• DOI: 10.1016/s1201-9712(10)60005-7